Ofer Shpilberg Selected Research

Ofer Shpilberg Research Topics

Disease

21	Neoplasms (Cancer) 01/2021 - 12/2006
18	Multiple Myeloma 09/2017 - 08/2008
15	Infections 12/2021 - 11/2003
14	Lymphoma (Lymphomas) 12/2019 - 11/2007
13	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 02/2009
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2016 - 06/2004
8	Leukemia 07/2022 - 01/2003
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2015 - 01/2008
7	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2021 - 04/2009
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 05/2006
6	Hematologic Neoplasms (Hematological Malignancy) 12/2021 - 01/2008
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019 - 09/2004
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2014 - 01/2003
5	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019 - 11/2007
5	Neutropenia 12/2017 - 03/2009
4	Disease Progression 01/2020 - 08/2008
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2017 - 10/2008
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016 - 05/2009
4	Acute Promyelocytic Leukemia 12/2013 - 01/2011
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2016 - 11/2003
3	Aplastic Anemia (Anemia, Hypoplastic) 01/2011 - 01/2008
3	Anemia 09/2009 - 09/2005
2	Erdheim-Chester Disease 11/2020 - 01/2020
2	Paraproteinemias (Monoclonal Gammopathy) 12/2017 - 05/2009
2	Hodgkin Disease (Hodgkin's Disease) 01/2017 - 01/2014
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2015 - 03/2014
2	Cytopenia 07/2013 - 04/2009
2	Second Primary Neoplasms (Neoplasms, Second) 02/2013 - 10/2011
2	Fever (Fevers) 08/2012 - 08/2011
2	Bacteremia 06/2012 - 03/2012
2	Invasive Fungal Infections 06/2012 - 03/2009
2	Peripheral Nervous System Diseases (PNS Diseases) 08/2011 - 01/2011
2	Thrombocytopenia (Thrombopenia) 08/2011 - 04/2009
2	Iron Deficiencies 09/2009 - 09/2005
2	Agammaglobulinemia (Hypogammaglobulinemia) 05/2009 - 10/2008
2	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2009 - 10/2008
1	Necrosis 07/2022
1	COVID-19 12/2021
1	Hypertension (High Blood Pressure) 12/2021
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 11/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2020

Drug/Important Bio-Agent (IBA)

21	Rituximab (Mabthera)FDA Link 12/2019 - 05/2006
14	Bortezomib (Velcade)FDA Link 11/2015 - 08/2008
13	Prednisone (Sone)FDA LinkGeneric 12/2019 - 05/2006
9	Melphalan (Alkeran)FDA LinkGeneric 06/2014 - 08/2008
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019 - 05/2006
7	Vincristine (Oncovin)FDA LinkGeneric 12/2019 - 05/2006
6	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 05/2006
6	Imatinib Mesylate (Gleevec)FDA Link 12/2013 - 01/2008
5	IronIBA 01/2021 - 09/2005
5	MicroRNAs (MicroRNA)IBA 11/2020 - 01/2012
5	Dexamethasone (Maxidex)FDA LinkGeneric 09/2017 - 01/2009
4	Pharmaceutical PreparationsIBA 03/2018 - 11/2003
4	Tyrosine Kinase InhibitorsIBA 01/2013 - 01/2008
3	NaphthoquinonesIBA 07/2022 - 11/2009
3	Biomarkers (Surrogate Marker)IBA 08/2021 - 05/2013
3	Deferasirox FDA Link 01/2021 - 04/2013
3	Cyclin D1IBA 01/2021 - 09/2010
3	fludarabineIBA 12/2017 - 11/2003
3	Monoclonal AntibodiesIBA 06/2014 - 07/2009
3	AntibodiesIBA 11/2012 - 05/2002
3	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 06/2012 - 01/2011
3	Immunoglobulins (Immunoglobulin)IBA 05/2009 - 10/2008
3	Intravenous Immunoglobulins (IVIG)FDA Link 05/2009 - 10/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 01/2008
2	Biological ProductsIBA 01/2018 - 01/2010
2	Bendamustine Hydrochloride FDA Link 12/2017 - 09/2012
2	Alkylating AgentsIBA 12/2017 - 11/2003
2	Lenalidomide (CC 5013)FDA Link 09/2017 - 01/2016
2	Prednisolone (Predate)FDA LinkGeneric 06/2017 - 05/2008
2	HematinicsIBA 01/2016 - 04/2011
2	Thalidomide (Thalomid)FDA Link 11/2015 - 01/2013
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2013 - 08/2013
2	Diphosphonates (Bisphosphonates)IBA 01/2013 - 05/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2010 - 05/2009
2	Ferritins (Ferritin)IBA 09/2009 - 09/2005
1	pyrrolidineIBA 07/2022
1	p38 Mitogen-Activated Protein KinasesIBA 07/2022
1	remdesivirIBA 12/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	Chelating AgentsIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Proteasome InhibitorsIBA 01/2021
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2021
1	EnzymesIBA 01/2021
1	cobimetinibIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	VemurafenibIBA 01/2020
1	CurcuminIBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2018

Therapy/Procedure

33	Therapeutics 12/2021 - 11/2003
24	Drug Therapy (Chemotherapy) 12/2019 - 11/2003
7	Cell Transplantation 10/2015 - 01/2011
7	Transplantation 10/2013 - 05/2009
4	Stem Cell Transplantation 12/2012 - 01/2009
3	Radiotherapy 12/2019 - 09/2004
2	Salvage Therapy 03/2016 - 12/2014
2	Organ Transplantation 10/2013 - 03/2013
2	Hematopoietic Stem Cell Transplantation 02/2009 - 10/2008
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 07/2004 - 06/2004